Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis.

Krowka, Michael; Cottreel, Emmanuelle; Hoeper, Marius M; Kim, Nick H; Martin, Nicolas; Sitbon, Olivier; Bosch, Jaume

Krowka, Michael; Cottreel, Emmanuelle; Hoeper, Marius M; Kim, Nick H; Martin, Nicolas; Sitbon, Olivier; Bosch, Jaume.

Krowka M; Division of Pulmonary Medicine, Mayo Clinic, Rochester, MN.
Cottreel E; Actelion Pharmaceuticals, Ltd., Allschwil, Switzerland.
Hoeper MM; Hannover Medical School and German Center of Lung Research, Hannover, Germany.
Kim NH; University of California, San Diego, La Jolla, CA.
Martin N; Actelion Pharmaceuticals, Ltd., Allschwil, Switzerland.
Sitbon O; University Paris-Saclay, Le Kremlin-Bicêtre, France.
Bosch J; Department of Respiratory Medicine, Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France.

Liver Transpl ; 26(7): 935-940, 2020 07.

Article en En | MEDLINE | ID: mdl-32150762

Asunto(s)

Hipertensión; Trasplante de Hígado; Humanos; Pirimidinas/uso terapéutico; Sulfonamidas/uso terapéutico

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Hígado / Hipertensión Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google